Journal of Limb Salvage (JoLS) is an open access, peer-reviewed, multidisciplinary medical journal. JoLS publishes original research articles on both clinical and experimental studies, systematic reviews, meta-analyses, case reports, case series, technical notes, editorials, editorial commentaries and letter to editor on limb salvage and relevant topics.
Journal of Limb Salvage will only evaluate submissions via online submission system at http://www.journaloflimbsalvage.org
Journal of Limb Salvage is published triannually (a volume per year). The journals’ title is abbreviated as "J Limb Salv"
The editorial board is the owner and executive of Journal of Limb Salvage. The editorial board of Journal of Limb Salvage have the authority of consultation of the submitted material to the advisory board and arbitration of publication.
Journal of Limb Salvage is strictly committed to the standards outlined by ICMJE regarding all aspects of publishing and all actors involved in the publication process, authors, journal editors and the publisher (http://www.icmje.org/). This concerns issues of publishing ethics, the publication itself, authorship, the author’s responsibilities, the peer review process, as well as the editor’s responsibilities.
The author(s) warrant that the manuscript that has been submitted to the Journal of Limb is original and has not been submitted for publication or published elsewhere. The author(s) also warrant full authority to submit the study. Journal of Limb Salvage will not accept a manuscript for which the copyright is held by a third party. (Please note that if the manuscript was a work made for hire, the employer as well as the author must sign this agreement). The author also warrants that the article contains no libelous or unlawful statements, and does not infringe on the rights of others. If the article contains any material protected by the copyright of others, the submitting author must deliver a written permission from the copyright owner(s) to reproduce such material in the article.
The authors should disclose financial relationship, conflict of interest, and competing interest that may potentially influence the results of the research or scientific judgement. All financial contributions or sponsorship, financial relations, and areas of conflict of interest should be clearly explained during submission, with full assurance that any related document will be submitted to the Journal of Limb Salvage when requested.
Manuscripts should be sent with the Copyright-Authors’ Approval-Conflict of Interest Letter signed by the author(s). Manuscripts will not be accepted for evaluation until the receipt of this document.
Journal of Limb Salvage also follows the standards and guidelines provided by the Committee on Publication Ethics (COPE), particularly regarding misconduct and fraud. For ethics in publishing consult COPE http://publicationethics.org/. To avoid plagiarism, duplicate manuscripts, fabrication and falsification of data and citations manipulation acts, Journal of Limb Salvage provides the evaluation and auditing of all submitted material by an expert group via up-to-date softwares (Turnitin and iThenticate).
All manuscripts presenting data of human subjects must include a statement in “Patients and Method” section that the informed consent of the volunteers was obtained and that the study was approved by an institutional review board. The same section should also include a statement that the study is in accordance with the World Medical Association Declaration of Helsinki (http://www.who.int/bulletin/archives/79(4)373.pdf), covering the latest revision date. Manuscripts reporting the results of experimental studies on animals must indicate whether institutional and national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available from the (http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors)
The authors are requested to send a copy of Institutional Review Board (IRB) or Independent Ethics Committee (IEC) approval for clinical studies, Ethics Committee approval for experimental studies together with submitted material.
All the articles published in Journal of Limb Salvage are licensed with "Creative Commons Attribution 4.0 International License". This license entitles all parties to copy, share and redistribute all the articles, data sets, figures and supplementary files published in this journal in data mining, search engines, web sites, blogs and other digital platforms under the condition of providing references.
Types of Papers
Original Study: The manuscripts of original clinical or experimental studies should not exceed 5000 words and should include Title, Abstract, Key words, Introduction, Patients and Methods, Results, Discussion and References sub-titles respectively.
Reviews: Extensive wide-ranging contemporary updated reviews of important aspect of limb salvage surgery and related issues are accepted. Each review should include a maximum of 5000 words with sub-titles and the abstract should not exceed 200 words. The maximum number of authors in reviews is limited to 3.
Case Presentations: The submissions should include unexpected or unusual presentations of a disease, symptom, diagnosis, management event in the course of observation and treatment method. Case presentations should not exceed 2000 words, 5 authors, 4 figures and 20 references.
Technical Notes: A new technique or a significant modification over an existing technique should be identified. Technical notes should not exceed 2000 words, 5 authors, 4 figures and 20 references.
Letter to Editor: Letters to editor are published under judicial discrection of editorial board. Letters should be concise with a figure or table, limited to 1500 words with a maximum of 10 references.
Main Manuscript Text Preperation
The official language of Journal of Limb Salvage is English. UK or American English spelling and terminology may be used, but the system chosen should be followed consistently throughout the article. We request that the language should be corrected before submission. Submissions with unsatisfactory English writing will be returned without review. All manuscripts should be edited in Microsoft Word XP or upper versions by PC compatible computers. The entire manuscript should be in font “Times New Roman” with size 12pt., double space line, single column with 1 inch or 2,5 cm wide margins.
The number of authors should not exceed 6 for clinical and experimental studies, 4 for case reports and technical notes, and 3 for letters to the editor. In multi-center or multi-disciplinary studies exceeding author limit, each author’s contribution should be stated clearly. For this kind of multi-center or multi-disciplinary studies with excessive number of authors, the editor has the right to request that the number of authors be reduced.
The manuscript should include the following sections consecutively: Title page, Abstract and Keywords, Manuscript, Figures and Tables, References.
The title should clearly indicate the content of the manuscript. The title should be followed by the first names (in low case letters) and last names (in capital letters) of the authors excluding academical degrees or titles. A footnote on the title page should give the hospital or university affiliation, city and title of each author, as well as the name, mailing address, city, telephone, fax and e-mail address of the corresponding author. The authors shall also specify in which institution the study was carried out. Conflict of interest statement should be placed at the bottom of title page.
Abstract: Abstract should not exceed 250 words. This section should start with a sentence emphasizing the rationale of the study and should briefly state findings and results.
Keywords: Keywords should be written regarding “Index Medicus” regulations (https://meshb.nlm.nih.gov/search). 3 to 5 keywords should represent the content of the article.
Manuscript:The manuscript should include Introduction, Patients/Materials and Methods, Results, and Discussion sections. The introduction should include brief information about the clinical problem with references and a clear definition of purpose of the study. The authors should use “Patients and Methods” for clinical studies, and “Materials and Methods” for animal and laboratory studies. The results section should include numerical data, which are supported by visuals, tables, figures and diagrams. The discussion section should address the study questions/purposes, evaluate and interpret the results with the most recent data in literature. The word count of this section should not exceed half of the study. Abbreviations should be defined at first use and standardized accordingly.
Tables and Captions: Tables and captions should be included starting from a separate page and legends of the tables should be identified below the table as a footnote.
Figures:All illustrations (photographs, diagrams, and drawings), artwork and numbers should be original and high quality. Copyrights and authorization permissions from copywright owner for the aforementioned material/data are under liability of the authors. The illustrations should be prepared as a separate digital file in “TIFF” format with 300 dpi or better resolution. Illustrations should be clean, distinguishable and legible. The illustrations should be numbered numbered consecutively and mentioned in the text. For recognizable photographs of human subjects, written permission signed by the patient or his/her legal representative should be submitted; otherwise, patient names or eyes must be blocked out to prevent identification. Microscopic photographs should include information on staining and magnification (e.g H & E x400). Figure captions should be concise, representing the summary of the results and should be placed at the end of the text in a double spaced fashion as a separate section. The authors should preserve a copy of the original artwork.
References:Following the discussion section, references should start from a separate page. References should be numbered in the order in which they are mentioned in the text with superscript. Only published articles or articles in press can be used in references. Journal titles should be abbreviated according to the “Index Medicus”. Unpublished data or personal communications cannot be used but can be indicated within the manuscript.
All the authors should be listed in references with four or fewer authors, otherwise, the remaining authors following the first three should be written as “et al.”
Reference Examples from
Standard Journal Articles:
Altundag O, Gullu I, Altundag K, et al. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Head Neck 2005; 27: 15-21.
Article in Press:
Cengiz M, Ozyigit G, Yazici G, et al. Salvage Reirradiaton with Stereotactic Body Radiotherapy for Locally Recurrent Head-and-Neck Tumors. Int J Radiat Oncol Biol Phys 2010 Jul 31. doi:10.1016/j.ijrobp.2010.04.027
Chao KSC, Ozyigit G. Intensity Modulated Radiation Therapy for Head&Neck Cancer. 1st edition. Philadelphia, Lippincott Williams & Wilkins, 2003: 34-36.
Ozyigit G, Beyzadeoglu M, Ebruli C. Genitourinary system cancers. In: Basic Radiation Oncology. Beyzadeoglu M, Ozyigit G, Ebruli C (eds). 1st edition. Springer-Verlag Berlin, Heidelberg, 2010: 363-410.
Appelbaum FR, Gilliland DG, Tallman MS. The biology and treatment of acute myeloid leukemia. In: 40th Annual Meeting of the American Society of Hematology Education Book. McArthur JR, Schechter GP, Schrier SL (eds). December 4-8, 1998, Miami Beach, Florida, 1998: 10-13.
Ayhan A, Yasui W, Yokozaki H, Tahara E. Gastrointestinal karsinomlarda bcl-2 ekspresyonu ve gen degisiklikleri. XII. National Cancer Congress, Antalya, April 23-26, 1997: P307.
Güllü IH. Mide kanserli hastalarda 5-florourasil, adriamisin, mitomisin kombine kemoterapisinin degerlendirilmesi. Hacettepe University Faculty of Medicine, Oncology Institute, Medical Oncology Department Graduate Thesis, Ankara, 1992.
http://www.cancer.gov/cancertopics/types/bladder (Access date: 12/14/208).
The submitted materials are subject to double blinded peer review by the advisory board members and the editor performs a final decision. Manuscripts and relevant material are assessed by the quality and relevance of the work. Since our purpose is to publish the best material, the estimated time to response is within 4 to 8 weeks
About Conflict of Interest and Copyright Notice
The authors should disclose all issues concerning financial relationship, conflict of interest, and competing interest that may potentially influence the results of the research or scientific judgement. All financial contributions or sponsorship, financial relations, and areas of conflict of interest should be clearly explained in a separate letter to the editor at the time of submission, with full assurance that any related document will be submitted to the Journal when requested.
Manuscripts should be sent with the Copyright Transfer Statement Form and Conflict of Interest Form signed by all authors. A copy of these forms can be found at http://www.journaloflimbsalvage.org. Manuscripts will not be accepted for evaluation until the receipt of this document by the Journal.
The author(s) must declare that they were involved in at least 3 of the 5 stages of the study stated in the “acknowledgement of authorship and transfer of copyright agreement” as “designing the study”, “collecting the data”, “analyzing the data”, “writing the manuscript” and “confirming the accuracy of the data and the analyses”. Those who do not fulfill this prerequisite should not be stated as an author.